BiotechTube
Home/Adecto Pharmaceuticals/Nora D. Mineva, PhD
ND

Nora D. Mineva, PhD

Co-founder, CEO & Chief Scientific Officer

Adecto Pharmaceuticals

Therapeutic Areas

Oncology

Adecto Pharmaceuticals Pipeline

DrugIndicationPhase
Anti-ADAM8 mAbADAM8-positive cancers (e.g., Colorectal, Breast, Kidney)Pre-clinical

Leadership Team at Adecto Pharmaceuticals

GE
Gail E. Sonenshein, PhD
Co-founder & President
SP
Stefania Pianetti, PhD
Head, Preclinical & Translational Development
JT
John Tagliamonte, MBA
Corporate Development Lead
View full Adecto Pharmaceuticals profile